Clinical Trials Insight: 700023957
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2008
At a glance
- Drugs Influenza virus vaccine (Primary) ; IC 31
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Intercell
- 27 Feb 2008 Status changed from in progress to completed according to a Intercell media release.
- 20 Nov 2007 All subjects have been vaccinated. Results expected in early 2008.
- 20 Nov 2007 Status changed from initiated to in progress.